A novel treatment proves successful in patients with INCURABLE cases of leukemia! 59 patients who had exhausted all other treatment options were treated with a new therapy at UPenn. Out of 32 adult patients with chronic lymphocytic leukemia (CLL), 15 responded to the treatment and 7 experienced complete remissions. All of the 5 first adult patients with acute lymphoblastic leukemia (ALL) experienced complete remissions!
But the most amazing results were seen in pediatric cancer patients! Out of 22 patients with ALL, 80% experienced complete remissions! And keep in mind- these were all patients whose cancer was completely resistant to all other types of chemotherapy and who would have died.
Here’s how it works: T-cells are collected from the patient and are then genetically modified so that they target tumor cells. These modified T-cells are then infused back into the patient, where they begin to do their jobs. Because the T-cells are made to target only the proteins expressed on cancer cells, normal cells are left alone. And these T-cells remain in the body, protecting patients from relapse! (Check out link below for details.)
Please take a minute and watch the videos in the below links- definitely worth your time! Amazing what research can do!